Pharmaceuticals are the next Trump tariff battleground - what will they mean for the NHS?
UK-based drug companies AstraZeneca and GSK could be affected by Trump’s next decision, as Karl Matchett reports
UK-based drug companies AstraZeneca and GSK could be affected by Trump’s next decision, as Karl Matchett reports
